DeepMed Research

BAYER AG

🇩🇪Germany

Country: 🇩🇪Germany

Ownership: Public

Established: 1863-08-01

Employees: 99.7K

Market Cap: $30.1B

Website: http://www.bayer.com

Clinical Trials

A Study Called NATION-OS to Learn About the Link Between N-terminal proBNP (NT-proBNP) Levels and Medical Problems Due to Heart Failure (HF) in German Patients With HF

Completed

Conditions: Heart Failure (HF)

Interventions: Other: Decompensation event

First Posted Date: 2021-06-07

Last Posted Date: 2022-12-02

Lead Sponsor: Bayer

Target Recruit Count: 169

Registration Number: NCT04915118

Locations: 🇩🇪
Many locations, Multiple Locations, Germany

A Study to Learn How BAY94-8862 Moves Into, Through and Out of the Body, How Safe it is and How it Affects the Body in Adult Participants With Reduced Kidney Function and in Healthy Participants With Similar Age, Weight and Gender Distribution

Phase 1

Completed

Conditions: Worsening Chronic Heart Failure
Chronic Kidney Disease

Interventions: Drug: Finerenone (BAY94-8862)

First Posted Date: 2021-06-01

Last Posted Date: 2022-01-28

Lead Sponsor: Bayer

Target Recruit Count: 33

Registration Number: NCT04908436

A Study to Learn How Different Levels of Decreased Liver Function Influence Blood Levels of Elinzanetant Compared to Normal Liver Function in Male and Female Participants

Phase 1

Completed

Conditions: Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men

Interventions: Drug: BAY3427080

First Posted Date: 2021-05-27

Last Posted Date: 2022-03-24

Lead Sponsor: Bayer

Target Recruit Count: 33

Registration Number: NCT04903821

Locations: 🇩🇪
CRS Clinical-Research-Services Kiel GmbH, Kiel, Schleswig-Holstein, Germany
🇩🇪
APEX GmbH, München, Bayern, Germany

A Study to Gather Information About User Satisfaction in Women in Russia Who Take Estradiol Valerate/Dienogest

Completed

Conditions: Oral Contraception

Interventions: Combination Product: Estradiol valerate/ Dienogest

First Posted Date: 2021-05-25

Last Posted Date: 2023-09-18

Lead Sponsor: Bayer

Target Recruit Count: 255

Registration Number: NCT04901377

Locations: 🇷🇺
Many locations, Multiple Locations, Russian Federation

A Study to Learn More About the Long-term Safety and Effectiveness of Molidustat as a Treatment for Japanese Men and Women With Renal Anemia

Active, not recruiting

Conditions: Renal Anemia

Interventions: Drug: Molidustat (Musredo, BAY85-3934)

First Posted Date: 2021-05-24

Last Posted Date: 2025-05-23

Lead Sponsor: Bayer

Target Recruit Count: 1500

Registration Number: NCT04899661

Locations: 🇯🇵
Many facilities, Multiple Locations, Japan

A Study to Learn How Much Rosuvastatin Gets Into the Blood When Taken With or Without Elinzanetant and to Learn About the Safety of Elinzanetant in Healthy Participants

Phase 1

Completed

Conditions: Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men

Interventions: Drug: Elinzanetant (BAY3427080)
Drug: Rosuvastatin

First Posted Date: 2021-05-17

Last Posted Date: 2023-08-09

Lead Sponsor: Bayer

Target Recruit Count: 16

Registration Number: NCT04889287

Locations: 🇩🇪
CRS Clinical-Research-Services Mannheim GmbH, Mannheim, Baden-Württemberg, Germany

A Study to Learn How Finerenone (BAY94-8862) Moves Into, Through and Out of the Body, How it Affects the Body, and How Safe it is in Adult Participants With Different Degrees of Reduced Liver Function and in Healthy Participants With Similar Age, Weight and Gender Distribution

Phase 1

Completed

Conditions: Diabetic Nephropathy
Worsening Chronic Heart Failure

Interventions: Drug: Finerenone (BAY94-8862)

First Posted Date: 2021-05-11

Last Posted Date: 2021-07-16

Lead Sponsor: Bayer

Target Recruit Count: 27

Registration Number: NCT04881994

A Study to Learn More About How Safe BAY2586116 is, How it Affects the Body, How it Moves Into, Through and Out of the Body at Different Doses in Healthy Japanese Male Participants After Taking Single and Multiple Doses Through the Nose

Phase 1

Completed

Conditions: Obstructive Sleep Apnea

Interventions: Drug: BAY2586116
Drug: Placebo

First Posted Date: 2021-05-04

Last Posted Date: 2023-03-01

Lead Sponsor: Bayer

Target Recruit Count: 36

Registration Number: NCT04872387

Locations: 🇯🇵
SOUSEIKAI Fukuoka Mirai Hospital, Fukuoka, Japan

A Trial to Learn What Happens to Different Medicinal Forms of BAY2328065 When They Enter the Body and How Safe They Are in Healthy Male and Female Participants

Phase 1

Completed

Conditions: Endometriosis

Interventions: Drug: BAY2328065
Drug: Placebo

First Posted Date: 2021-04-20

Last Posted Date: 2022-06-01

Lead Sponsor: Bayer

Target Recruit Count: 31

Registration Number: NCT04851483

Locations: 🇩🇪
CRS Clinical-Research-Services Mannheim GmbH, Mannheim, Baden-Württemberg, Germany

COVID-19: A Trial Studying the SARS-CoV-2 mRNA Vaccine CVnCoV to Learn About the Immune Response, the Safety, and the Degree of Typical Vaccination Reactions When CVnCoV is Given at the Same Time as a Flu Vaccine Compared to When the Vaccines Are Separately Given in Adults 60 Years of Age and Older

Phase 3

Withdrawn

Conditions: SARS-CoV-2 Infection
Coronavirus Disease 2019 (COVID-19)

Interventions: Biological: SARS-CoV-2 mRNA Vaccine (CVnCoV)
Biological: Quadrivalent influenza vaccine (QIV)
Other: Placebo

First Posted Date: 2021-04-19

Last Posted Date: 2021-08-11

Lead Sponsor: Bayer

Registration Number: NCT04848467

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy